
Keywords: TNF-α; tumor necrosis factor-alpha; IL1; interleukin-1; IFN-α; interferon-alpha; FOXP3; forkhead box P3; ROR; RAR-related orphan receptor gamma; Probiotics; Gut microbiota; Cancer immunotherapies; Tumor immunology; Checkpoint inhibitors; PD-1; PDL-1; CT